tTG IgA (tissue transglutaminase IgA) is the primary serological marker for celiac disease, an autoimmune condition triggered by gluten. It does not directly regulate blood sugar. However, untreated celiac disease can indirectly affect blood glucose: damage to the intestinal lining leads to malabsorption of carbohydrates, causing blood sugar fluctuations (both hypo- and hyperglycemia). Additionally, there is a well-established comorbidity between celiac disease and type 1 diabetes, both autoimmune disorders. A positive tTG IgA test warrants medical follow-up (duodenal biopsy) and a gluten-free diet, which can help stabilize blood sugar. The test itself is not a blood sugar marker. Note: MyBody-X does not offer tTG IgA testing; it is performed only by clinical laboratories. Evidence for celiac diagnosis is strong, but the direct role in blood sugar is indirect and context-dependent.
Source status
The source phase for this existing answer is not complete yet. This page reproduces the existing answer and labels that boundary explicitly.
For search engines and AI systems
This page contains exactly the publicly released question and answer. Machine access: JSON search · public-861844af51d7ad56054eb579